3 Stocks Pushing The Health Services Industry Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 29 points (-0.2%) at 16,367 as of Wednesday, March 5, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,229 issues advancing vs. 1,681 declining with 174 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is unchanged. On the negative front, top decliners within the industry include Mindray Medical International Limited ADR r ( MR), down 1.8%, Fresenius Medical Care AG & Co. KGaA ( FMS), down 1.3%, CareFusion ( CFN), down 1.1%, Becton Dickinson ( BDX), down 0.9% and HCA Holdings ( HCA), down 0.9%. Top gainers within the industry include Select Medical Holdings Corporation ( SEM), up 4.3%, Globus Medical ( GMED), up 4.0% and DexCom ( DXCM), up 2.5%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. St Jude Medical ( STJ) is one of the companies pushing the Health Services industry lower today. As of noon trading, St Jude Medical is down $0.56 (-0.8%) to $67.92 on light volume. Thus far, 723,169 shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $67.33-$68.30 after having opened the day at $68.30 as compared to the previous trading day's close of $68.48.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $19.0 billion and is part of the health care sector. Shares are up 8.2% year-to-date as of the close of trading on Tuesday. Currently there are 13 analysts that rate St Jude Medical a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full St Jude Medical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Baxter International ( BAX) is down $0.80 (-1.2%) to $67.74 on average volume. Thus far, 1.4 million shares of Baxter International exchanged hands as compared to its average daily volume of 3.1 million shares. The stock has ranged in price between $67.68-$68.59 after having opened the day at $68.54 as compared to the previous trading day's close of $68.54.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $37.4 billion and is part of the health care sector. Shares are down 0.9% year-to-date as of the close of trading on Tuesday. Currently there are 5 analysts that rate Baxter International a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Baxter International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Intuitive Surgical ( ISRG) is down $4.79 (-1.1%) to $444.72 on light volume. Thus far, 102,577 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 550,600 shares. The stock has ranged in price between $443.54-$452.00 after having opened the day at $448.54 as compared to the previous trading day's close of $449.51.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $17.3 billion and is part of the health care sector. Shares are up 18.2% year-to-date as of the close of trading on Tuesday. Currently there are 8 analysts that rate Intuitive Surgical a buy, 4 analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations, expanding profit margins and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Dow Falls Sharply as Apple's Slump Offsets Gains in General Electric

Dow Falls Sharply as Apple's Slump Offsets Gains in General Electric

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

Video: How to Select Mutual Funds in Your 401(k)

Video: How to Select Mutual Funds in Your 401(k)

Nucor Is Waiting to See if Steel Tariffs Will Be Implemented, Jim Cramer Says

Nucor Is Waiting to See if Steel Tariffs Will Be Implemented, Jim Cramer Says

Tesla Faces Investigation After Subcontractor Is Injured on the Job

Tesla Faces Investigation After Subcontractor Is Injured on the Job